Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008-2019

• Main Authors: Anna Maisa (Author), Christian Kollan (Author), Matthias an der Heiden (Author), Florian van Bömmel (Author), Markus Cornberg (Author), Stefan Mauss (Author), Heiner Wedemeyer (Author), Daniel Schmidt (Author), Sandra Dudareva (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Germany is a low prevalence country for hepatitis B virus (HBV) infection with higher prevalence in vulnerable groups. The number of treated chronic hepatitis B (CHB) patients is unknown. We aimed to determine the number of CHB patients treated with nucleos(t)ide analogs (NUCs), the trea...